Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas

P Borchmann; F Morschhauser; A Parry; R Schnell; JL Harousseau; C Gisselbrecht; C Rudolph; Martin Wilhelm; HG Derigs; M Pfreundschuh; G Camboni; A Engert

Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas

P Borchmann
, F Morschhauser
, A Parry
, R Schnell
, JL Harousseau
, C Gisselbrecht
, C Rudolph
, Martin Wilhelm (Co-Autor/-in)
, HG Derigs
, M Pfreundschuh
, G Camboni
, A Engert

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

42 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	888-894
Fachzeitschrift	HAEMATOLOGICA
Jahrgang	88
Ausgabenummer	8
Publikationsstatus	Veröffentlicht - 2003

Zugriff auf Dokument

http://www.haematologica.org/content/88/8/888.full-text.pdf+html

Dieses zitieren

Borchmann, P., Morschhauser, F., Parry, A., Schnell, R., Harousseau, JL., Gisselbrecht, C., Rudolph, C., Wilhelm, M., Derigs, HG., Pfreundschuh, M., Camboni, G., & Engert, A. (2003). Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas. HAEMATOLOGICA , 88(8), 888-894. http://www.haematologica.org/content/88/8/888.full-text.pdf+html

Borchmann, P ; Morschhauser, F ; Parry, A et al. / Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas. in: HAEMATOLOGICA 2003 ; Jahrgang 88, Nr. 8. S. 888-894.

@article{6ee947ea9cea4acb92587f332918b332,

title = "Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas",

keywords = "CONTINUOUS-INFUSION, CELL LYMPHOMA, MITOXANTRONE, DOXORUBICIN, CARDIOTOXICITY, REGIMEN, TRIAL, AMETANTRONE, PACLITAXEL, IFOSFAMIDE",

author = "P Borchmann and F Morschhauser and A Parry and R Schnell and JL Harousseau and C Gisselbrecht and C Rudolph and Martin Wilhelm and HG Derigs and M Pfreundschuh and G Camboni and A Engert",

year = "2003",

language = "English",

volume = "88",

pages = "888--894",

journal = "HAEMATOLOGICA ",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "8",

}

Borchmann, P, Morschhauser, F, Parry, A, Schnell, R, Harousseau, JL, Gisselbrecht, C, Rudolph, C, Wilhelm, M, Derigs, HG, Pfreundschuh, M, Camboni, G & Engert, A 2003, 'Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas', HAEMATOLOGICA , Jg. 88, Nr. 8, S. 888-894. <http://www.haematologica.org/content/88/8/888.full-text.pdf+html>

Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas. / Borchmann, P; Morschhauser, F; Parry, A et al.
in: HAEMATOLOGICA , Jahrgang 88, Nr. 8, 2003, S. 888-894.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas

AU - Borchmann, P

AU - Morschhauser, F

AU - Parry, A

AU - Schnell, R

AU - Harousseau, JL

AU - Gisselbrecht, C

AU - Rudolph, C

AU - Wilhelm, Martin

AU - Derigs, HG

AU - Pfreundschuh, M

AU - Camboni, G

AU - Engert, A

PY - 2003

Y1 - 2003

KW - CONTINUOUS-INFUSION

KW - CELL LYMPHOMA

KW - MITOXANTRONE

KW - DOXORUBICIN

KW - CARDIOTOXICITY

KW - REGIMEN

KW - TRIAL

KW - AMETANTRONE

KW - PACLITAXEL

KW - IFOSFAMIDE

M3 - Original Article

C2 - 12935976

SN - 0390-6078

VL - 88

SP - 888

EP - 894

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

IS - 8

ER -

Borchmann P, Morschhauser F, Parry A, Schnell R, Harousseau JL, Gisselbrecht C et al. Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas. HAEMATOLOGICA . 2003;88(8):888-894.